Open Access<p>Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations</p>
Author(s) -
Xing Li,
Weihua Zhang,
Yuqi Zhou,
Yanying Ji,
Weizhan Li,
Liyi Zhang,
Vivian Yawei Guo,
Ding-Yun Feng,
Tiantuo Zhang
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s225544
Subject(s) - medicine , docetaxel , pemetrexed , oncology , neutrophil to lymphocyte ratio , chemotherapy , lung cancer , stage (stratigraphy) , gastroenterology , proportional hazards model , lymphocyte , cisplatin , biology , paleontology
To investigate the predictive capability of clinical parameters for long-term chemotherapy benefits among stage IIIB-IV non-squamous non-small cell lung cancer (NSCLC) patients without sensitive mutations.